FR2833008B1 - 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation - Google Patents

1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation

Info

Publication number
FR2833008B1
FR2833008B1 FR0115739A FR0115739A FR2833008B1 FR 2833008 B1 FR2833008 B1 FR 2833008B1 FR 0115739 A FR0115739 A FR 0115739A FR 0115739 A FR0115739 A FR 0115739A FR 2833008 B1 FR2833008 B1 FR 2833008B1
Authority
FR
France
Prior art keywords
diarylprop
ones
compositions containing
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0115739A
Other languages
English (en)
Other versions
FR2833008A1 (fr
Inventor
Patrick Maillet
Cecile Combeau
Marie Christine Bissery
Marie Pierre Cherrier
Thomas Caulfield
Gilles Tiraboschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0115739A priority Critical patent/FR2833008B1/fr
Priority to PE2002001118A priority patent/PE20030758A1/es
Priority to PA20028558501A priority patent/PA8558501A1/es
Priority to TW091134346A priority patent/TW200300685A/zh
Priority to ARP020104618A priority patent/AR037479A1/es
Priority to GT200200252A priority patent/GT200200252A/es
Priority to SV2002001422A priority patent/SV2003001422A/es
Priority to PL02370676A priority patent/PL370676A1/xx
Priority to AU2002365644A priority patent/AU2002365644A1/en
Priority to YU47804A priority patent/RS47804A/sr
Priority to IL16222302A priority patent/IL162223A0/xx
Priority to KR1020047008656A priority patent/KR20050044712A/ko
Priority to EP02804242A priority patent/EP1453790A2/fr
Priority to JP2003549299A priority patent/JP2005531494A/ja
Priority to NZ533224A priority patent/NZ533224A/xx
Priority to BR0214694-0A priority patent/BR0214694A/pt
Priority to MXPA04005226A priority patent/MXPA04005226A/es
Priority to CA002469193A priority patent/CA2469193A1/fr
Priority to HU0500100A priority patent/HUP0500100A2/hu
Priority to PCT/FR2002/004143 priority patent/WO2003048106A2/fr
Priority to CNA028268601A priority patent/CN1612856A/zh
Priority to EA200400764A priority patent/EA006803B1/ru
Priority to US10/309,076 priority patent/US20040147584A2/en
Publication of FR2833008A1 publication Critical patent/FR2833008A1/fr
Application granted granted Critical
Publication of FR2833008B1 publication Critical patent/FR2833008B1/fr
Priority to MA27708A priority patent/MA27351A1/fr
Priority to ZA200404390A priority patent/ZA200404390B/en
Priority to CO04052091A priority patent/CO5580759A2/es
Priority to HR20040508A priority patent/HRP20040508A2/hr
Priority to NO20042803A priority patent/NO20042803L/no
Priority to US11/108,855 priority patent/US20050203170A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32N-nitroguanidines
    • C07C279/36Substituted N-nitroguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
FR0115739A 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation Expired - Fee Related FR2833008B1 (fr)

Priority Applications (29)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
PE2002001118A PE20030758A1 (es) 2001-12-05 2002-11-21 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
PA20028558501A PA8558501A1 (es) 2001-12-05 2002-11-22 1,3-diarilprop-2-en1-onas, composiciones que las contienen y su utilizacion
TW091134346A TW200300685A (en) 2001-12-05 2002-11-26 1, 3-diarylprop-2-en-1-ones, compositions containing them and use thereof
ARP020104618A AR037479A1 (es) 2001-12-05 2002-11-29 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
GT200200252A GT200200252A (es) 2001-12-05 2002-11-29 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
SV2002001422A SV2003001422A (es) 2001-12-05 2002-12-02 "1,3-diarilprop-2-en-1-onas,composiciones que las contienen y su utilizacion"
CNA028268601A CN1612856A (zh) 2001-12-05 2002-12-03 1,3-二芳基丙-2-烯-1-酮、含有它们的组合物及其用途
YU47804A RS47804A (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
IL16222302A IL162223A0 (en) 2001-12-05 2002-12-03 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof
KR1020047008656A KR20050044712A (ko) 2001-12-05 2002-12-03 1,3-디아릴프로프-2-엔-1-온, 이를 함유하는 조성물 및이의 용도
EP02804242A EP1453790A2 (fr) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
JP2003549299A JP2005531494A (ja) 2001-12-05 2002-12-03 1,3−ジアリールプロパ−2−エン−1−オン、これを含有する組成物及びその使用
NZ533224A NZ533224A (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
PL02370676A PL370676A1 (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
MXPA04005226A MXPA04005226A (es) 2001-12-05 2002-12-03 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion.
CA002469193A CA2469193A1 (fr) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
HU0500100A HUP0500100A2 (hu) 2001-12-05 2002-12-03 1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PCT/FR2002/004143 WO2003048106A2 (fr) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
AU2002365644A AU2002365644A1 (en) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof
EA200400764A EA006803B1 (ru) 2001-12-05 2002-12-03 1,3-диарилпроп-2-ен-1-оны, композиция на их основе и применение
BR0214694-0A BR0214694A (pt) 2001-12-05 2002-12-03 1,3-diarilprop-2-en-1-onas, composições que as contêm e utilização
US10/309,076 US20040147584A2 (en) 2001-12-05 2002-12-04 1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof
MA27708A MA27351A1 (fr) 2001-12-05 2004-06-01 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
ZA200404390A ZA200404390B (en) 2001-12-05 2004-06-03 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof.
CO04052091A CO5580759A2 (es) 2001-12-05 2004-06-03 1-3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
HR20040508A HRP20040508A2 (en) 2001-12-05 2004-06-04 1,3-diarylprop-2-en-1-ones, compositions containing the same and use thereof
NO20042803A NO20042803L (no) 2001-12-05 2004-07-02 1,3-diarylprop-2en-1-oner, preparater inneholdende forbindelsene samt anvendelse derav
US11/108,855 US20050203170A1 (en) 2001-12-05 2005-04-19 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation

Publications (2)

Publication Number Publication Date
FR2833008A1 FR2833008A1 (fr) 2003-06-06
FR2833008B1 true FR2833008B1 (fr) 2004-05-21

Family

ID=8870150

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0115739A Expired - Fee Related FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation

Country Status (4)

Country Link
FR (1) FR2833008B1 (fr)
GT (1) GT200200252A (fr)
NO (1) NO20042803L (fr)
ZA (1) ZA200404390B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
WO1999000114A2 (fr) * 1997-06-26 1999-01-07 Statens Serum Institut 1,3-bis-aromatique-prop-2-en-1-ones, 1,3-bis-aromatique-propane-1-ones et 1,3-bis-aromatique-prop-2-yn-1-ones a action biologique

Also Published As

Publication number Publication date
GT200200252A (es) 2003-11-11
ZA200404390B (en) 2005-02-07
FR2833008A1 (fr) 2003-06-06
NO20042803L (no) 2004-08-31

Similar Documents

Publication Publication Date Title
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
ATE214590T1 (de) Körperpflegezusammensetzungen
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
FR2843023B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
FR2824267B1 (fr) Composition cosmetique filmogene
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
ATE300177T1 (de) Pestizide zusammensetzung
AR028610A1 (es) Composiciones antitranspirantes y/o desodorantes
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
DK1425005T3 (da) Farmaceutisk sammensætning indeholdende lumiracoxib
DE975695T1 (de) Zusammensetzungen, enthaltend gleit- und antiblockmittel
FR2833599B1 (fr) Polysaccharide amphotere, composition et utilisation
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
ATE269639T1 (de) Pestizide zusammensetzung
FR2784381B1 (fr) Compose fongicide, composition le contenant et son utilisation
MA27351A1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR2819176B1 (fr) Composition cosmetique pelable
FR2823754B1 (fr) Peptides antibacteriens, les compositions les contenant et leurs utilisations
FR2855825B1 (fr) Produits aryl-heteroaromatiques, compositions les contenant et utilisation
FR2777005B1 (fr) Compose stabilisant, composition le contenant et son utilisation
FR2833004B1 (fr) Aryl-cycloalcaines substitues, compositions les contenant et utilisation
FR2833008B1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081020